Literature DB >> 24612179

Hysteroscopy in patients with repeated implantation failure improves the outcome of assisted reproductive technology in fresh and frozen cycles.

Marzieh Agha Hosseini1, Nasim Ebrahimi, Atossa Mahdavi, Ashraf Aleyasin, Leili Safdarian, Parvin Fallahi, Fatemeh Esfahani.   

Abstract

AIM: Repeated implantation failure (RIF) is still a problem for many patients and their physicians. Some interventions have been practiced to overcome the problem; one is uterine cavity assessment before assisted reproductive technology (ART) cycles. This study aimed to evaluate the effect of hysteroscopy in women experiencing recurrent implantation failure with apparently normal uterine cavity before assisted reproductive techniques.
MATERIAL AND METHODS: This was a cohort study with historical controls conducted in a university hospital. A total of 353 women with RIF undergoing ART with normal hysterosalpingography and transvaginal ultrasound were evaluated. The intervention group underwent hysteroscopy with a rigid, 30°, 4-mm hysteroscope in the menstrual cycle just before ART; in the control group hysteroscopy was not performed. Basal characteristics, stimulation parameters and pregnancy rates were compared between the two groups.
RESULTS: Chemical pregnancy occurred in 58.5% of women in the hysteroscopy group versus 34.1% of control women (odds ratio [OR]: 2.7; 95% confidence interval [CI]: 1.7-4.2; P < 0.001). Clinical pregnancy occurred in 50.7% and 30.3% of women in the hysteroscopy and control groups, respectively (OR: 2.4; 95%CI: 1.5-3.7; P < 0.001). Delivery rate was 35.5% in hysteroscopy women and 21.1% in control women (OR: 1.9; 95%CI: 1.2-3.1; P = 0.008). The results of hysteroscopy were normal in 103 women (72.5%), and they revealed inflammation in 22 (15.5%), polyp in 16 (11.3%) and Asherman syndrome in one patient (0.7%).
CONCLUSIONS: Hysteroscopy in the menstrual cycle before ovarian stimulation in fresh cycles and before endometrial preparation in frozen thawed cycles in women experiencing recurrent implantation failure with apparently normal uterine cavity significantly increases the pregnancy rates in fresh and frozen cycles, respectively.
© 2014 The Authors. Journal of Obstetrics and Gynaecology Research © 2014 Japan Society of Obstetrics and Gynecology.

Entities:  

Keywords:  assisted reproductive technology; fresh; hysteroscopy; implantation failure; pregnancy

Mesh:

Year:  2014        PMID: 24612179     DOI: 10.1111/jog.12315

Source DB:  PubMed          Journal:  J Obstet Gynaecol Res        ISSN: 1341-8076            Impact factor:   1.730


  5 in total

1.  Accuracy of Two-Dimensional Transvaginal Sonography and Office Hysteroscopy for Detection of Uterine Abnormalities in Patients with Repeated Implantation Failures or Recurrent Pregnancy Loss.

Authors:  Marzieh Shiva; Firouzeh Ahmadi; Arezoo Arabipoor; Mansoureh Oromiehchi; Mohammad Chehrazi
Journal:  Int J Fertil Steril       Date:  2017-10-12

2.  Effect of hysteroscopy before starting in-vitro fertilization for women with recurrent implantation failure: A meta-analysis and systematic review.

Authors:  Xiaoyan Mao; Ling Wu; Qiuju Chen; Yanping Kuang; Shaozhen Zhang
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

3.  Efficacy of therapies and interventions for repeated embryo implantation failure: a systematic review and meta-analysis.

Authors:  Andrea Busnelli; Edgardo Somigliana; Federico Cirillo; Annamaria Baggiani; Paolo Emanuele Levi-Setti
Journal:  Sci Rep       Date:  2021-01-18       Impact factor: 4.379

4.  Impact of endometrial scratching on reproductive outcome in patients: A systematic review and meta-analysis.

Authors:  YiFan Kang; ZhiHong Wang; Yuan Yang; HuiZhi Liang; Xia Duan; QingZhuo Gao; ZhaoFang Yin
Journal:  Medicine (Baltimore)       Date:  2022-08-19       Impact factor: 1.817

5.  Multivariate Analysis of Recurrence after Hysteroscopic Diagnosis and Treatment of Endometrial Polyps following IVF-ET Failure.

Authors:  Jing Xu; Bao Liu; Xue Feng; Liyuan Shen; Qinghua Qu
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-14       Impact factor: 2.650

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.